Olink Investor Relations Material
Latest events
Q2 2023
Olink
Q1 2024
13 May, 2024
Q4 2023
25 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Olink Holding AB
Access all reports
Olink Holding AB develops and markets proteomics solutions for academic and pharmaceutical research. The company’s technology platform enables high-throughput protein biomarker discovery and validation. It serves customers in biomarker research, drug development, and diagnostics. The company is headquartered in Uppsala, Sweden, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
OLK
Country
🇺🇸 United States